购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Antibiotic
    (1)
  • Antifungal
    (1)
  • Apoptosis
    (1)
  • IRE1
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (38)
  • 5日内发货
    (12)
  • 8-10周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "drug screening"的结果
筛选
搜索结果
TargetMol产品目录中 "

drug screening

"的结果
  • 抑制剂&激动剂
    7
    TargetMol | Inhibitors_Agonists
  • 化合物库
    153
    TargetMol | Compound_Libraries
  • 天然产物
    2
    TargetMol | Natural_Products
  • 试剂盒
    16
    TargetMol | Reagent_Kits
  • Toyocamycin
    丰加霉素, Vengicide
    T17143606-58-6
    Toyocamycin (Vengicide) 是放线菌类产生的腺苷类似物,为 X 盒结合蛋白 1 (XBP1) 抑制剂,抑制 IRE1α 诱导的 ATP 依赖性 XBP1 mRNA 的断裂,IC50值为 80 nM。它还诱导凋亡。
    • ¥ 163
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • PD 198306
    T21980212631-61-3In house
    PD 198306 是一种具有抗痛觉过敏作用的 MAPK ERK 激酶 (MEK) 选择性抑制剂。 PD 198306 可降低链脲佐菌素诱导的活性 ERK1 水平升高。
    • ¥ 432
    In stock
    规格
    数量
  • Compound V007-6018
    T67752859093-06-4In house
    Compound V007-6018是一种类药化合物,用于药物筛选。
    • ¥ 2300
    In stock
    规格
    数量
  • (Z)-2-fluoro-1,3-bis(4-methoxyphenyl)prop-2-en-1-one
    SJD00639
    T85319126912-62-7In house
    (Z)-2-fluoro-1,3-bis(4-methoxyphenyl)prop-2-en-1-one 是一种筛选化合物,可用于新药研发相关研究。
    • 待询
    规格
    数量
  • TAS-103
    T36695174634-08-3
    TAS-103 is a dual inhibitor of DNA topoisomerase I II, used for cancer research. TAS-103 is a dual inhibitor of DNA topoisomerase I II. TAS-103 (0.1-10 μM) is active on CCRF-CEM cells, with an IC50 value of 5 nM. TAS-103 (0.1 μM) significantly increases levels of topo IIα FITC immunofluorescence in individual CCRF-CEM cells[1]. TAS-103 (0.01-1 μM) is highly cytotoxic to Lewis lung carcinoma (LLC) cells, and Liposomal TAS-103 is almost as active as free TAS-103[2]. TAS-103 inhibits the viability of HeLa cells, with an IC50 of 40 nM. TAS-103 (10 μM) disrupts signal recognition particle (SRP) complex formation, and induces destabilization of SRP14 and SRP19 and its eventual degradation[3]. TAS-103 (30 mg kg, i.v.) causes significant tumor growth suppression in mice bearing Lewis lung carcinoma (LLC) cells, without obvious body weight loss, and the liposomal TAS-103 is more active than free TAS-103[2]. [1]. Padget K, et al. An investigation into the formation of N- [2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 6-[2-(dimethylamino)ethylamino]- 3-hydroxy-7H-indeno[2, 1-C]quinolin-7-one dihydrochloride (TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia cells. Biochem Pharmacol. 2000 Sep 15;60(6):817-21. [2]. Shimizu K, et al. Cancer chemotherapy by liposomal 6-[12-(dimethylamino)ethyl]aminol-3-hydroxy-7H-indeno[2,1-clquinolin-7-one dihydrochloride (TAS-103), a novel anti-cancer agent. Biol Pharm Bull. 2002 Oct;25(10):1385-7. [3]. Yoshida M, et al. A new mechanism of 6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one dihydrochloride (TAS-103) action discovered by target screening with drug-immobilized affinity beads. Mol Pharmacol. 2008 Mar;73(3):987-94. Epub 2007 Dec 18.
    • ¥ 1680
    待询
    规格
    数量
  • Coptisine sulfate
    硫酸黄连碱
    T4S00511198398-71-8
    Coptisine Sulfate 是一种从黄连中分离到的生物碱,是非竞争性的IDO 抑制剂,Ki=为 5.8 μM,IC50=6.3 μM。
    • ¥ 250
    In stock
    规格
    数量
  • CYT296
    T785201799392-31-6
    CYT296是一种靶向染色质去凝集的化合物,能增强定义因子(OSKM)介导诱导多能干细胞(iPSC)的生成,并通过诱导小鼠胚胎成纤维细胞(MEFs)染色质的开放状态来促进体细胞的重编程,适用于细胞替代治疗和药物筛选的研究领域。
    • 待询
    8-10周
    规格
    数量